Read Books Online and Download eBooks, EPub, PDF, Mobi, Kindle, Text Full Free.
Building The Case For Biotechnology
Download Building The Case For Biotechnology full books in PDF, epub, and Kindle. Read online Building The Case For Biotechnology ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Book Synopsis Building the Case for Biotechnology by : Mark J. Ahn
Download or read book Building the Case for Biotechnology written by Mark J. Ahn and published by . This book was released on 2010 with total page 412 pages. Available in PDF, EPUB and Kindle. Book excerpt: This volume helps to fill the void in life science entrepreneurship and management case books and provides faculty and students with not only the charts, but the simulated experience of sailing the turbulent and exciting oceans of the biomedical industry toward creating significant value for patients and society.
Book Synopsis Biotechnology and Genetic Engineering by : Kathy Wilson Peacock
Download or read book Biotechnology and Genetic Engineering written by Kathy Wilson Peacock and published by Infobase Publishing. This book was released on 2010 with total page 369 pages. Available in PDF, EPUB and Kindle. Book excerpt: Explains why biotechnology is a relevant and volatile issues. Begins with a history of biotechnology and its effect on agriculture, medicine, and the environment. Equal space is devoted to discussing the efforts of human-rights advocates, animal-rights advocates, and environmentalists to create definitive governmental regulations for this budding industry.
Book Synopsis Building Biotechnology by : Yali Friedman
Download or read book Building Biotechnology written by Yali Friedman and published by . This book was released on 2014 with total page 367 pages. Available in PDF, EPUB and Kindle. Book excerpt: Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, policy, regulatory, and commercial factors that drive the biotechnology industry and define its scope. In addition to its popularity among business professionals and scientists seeking to apply their skills to biotechnology, Building Biotechnology has also been adopted as a course text in dozens of advanced biotechnology programs. This fourth edition significantly expands upon the foundation laid by the first three, updating case law and business models in this dynamic industry and adding significantly more case studies, informative figures and tables. Most importantly, Building Biotechnology enables seasoned business professionals and entrepreneurial scientists alike to understand the drivers of biotechnology businesses and apply their established skills for commercial success.
Book Synopsis Building Biotechnology by : Yali Friedman
Download or read book Building Biotechnology written by Yali Friedman and published by Thinkbiotech. This book was released on 2006 with total page 306 pages. Available in PDF, EPUB and Kindle. Book excerpt: Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry: * Cultivate a career in biotechnology, with or without an MBA or Ph.D. * Fund and assemble a company * Manage research and development, alliances, and funding * Understand the diverse factors defining the biotechnology industry * Invest intelligently in biotechnology This second edition significantly expands upon the foundation laid by the first, updating recent developments and adding significantly more case studies, informative figures and tables.
Book Synopsis Building Global Biobrands by : Françoise Simon
Download or read book Building Global Biobrands written by Françoise Simon and published by Simon and Schuster. This book was released on 2003 with total page 360 pages. Available in PDF, EPUB and Kindle. Book excerpt: Two foremost marketing strategists combine their expertise in the first ever book to offer cutting-edge global strategies for marketing biotechnology. 20 charts & graphs.
Book Synopsis Building Biotechnology by : Yali Friedman
Download or read book Building Biotechnology written by Yali Friedman and published by Logos Press. This book was released on 2014-01-01 with total page 388 pages. Available in PDF, EPUB and Kindle. Book excerpt: Building Biotechnology helps readers start and manage biotechnology companies and understand the business of biotechnology. This acclaimed book describes the convergence of scientific, policy, regulatory, and commercial factors that drive the biotechnology industry and define its scope. In addition to its popularity among business professionals and scientists seeking to apply their skills to biotechnology, Building Biotechnology has also been adopted as a course text in dozens of advanced biotechnology programs. This fourth edition significantly expands upon the foundation laid by the first three, updating case law and business models in this dynamic industry and adding significantly more case studies, informative figures and tables. Most importantly, Building Biotechnology enables seasoned business professionals and entrepreneurial scientists alike to understand the drivers of biotechnology businesses and apply their established skills for commercial success.
Book Synopsis Building Biotechnology by : Yali Friedman
Download or read book Building Biotechnology written by Yali Friedman and published by Thinkbiotech. This book was released on 2004 with total page 264 pages. Available in PDF, EPUB and Kindle. Book excerpt: Building Biotechnology helps readers understand the business of biotechnology, how to start and manage biotechnology companies, and how to better service the needs of biotechnology companies. This acclaimed book describes the convergence of scientific, political, regulatory, and commercial factors that drive the biotechnology industry and define its scope. In addition to its popularity among business professionals and scientists seeking to apply their skills to biotechnology, Building Biotechnology has also been adopted as a course text in dozens of advanced biotechnology programs including MBA programs at UC Irvine, Tepper, and Boston University; the Johns Hopkins biotechnology MS/MBA program; NIH Office of Technology Transfer; extension programs at Berkeley and UCSF; and international programs at the Karolinska Institute, Macquarie University, and Schulich School of Business. This fourth edition significantly expands upon the foundation laid by the first three, updating case law and business models in this dynamic industry and adding significantly more case studies, informative figures and tables. Most importantly, Building Biotechnology enables seasoned business professionals and entrepreneurial scientists alike to understand the drivers of biotechnology businesses and apply their established skills for commercial success.
Book Synopsis Biotechnology Entrepreneurship by : Craig Shimasaki
Download or read book Biotechnology Entrepreneurship written by Craig Shimasaki and published by Academic Press. This book was released on 2014-04-08 with total page 489 pages. Available in PDF, EPUB and Kindle. Book excerpt: As an authoritative guide to biotechnology enterprise and entrepreneurship, Biotechnology Entrepreneurship and Management supports the international community in training the biotechnology leaders of tomorrow. Outlining fundamental concepts vital to graduate students and practitioners entering the biotech industry in management or in any entrepreneurial capacity, Biotechnology Entrepreneurship and Management provides tested strategies and hard-won lessons from a leading board of educators and practitioners. It provides a ‘how-to’ for individuals training at any level for the biotech industry, from macro to micro. Coverage ranges from the initial challenge of translating a technology idea into a working business case, through securing angel investment, and in managing all aspects of the result: business valuation, business development, partnering, biological manufacturing, FDA approvals and regulatory requirements. An engaging and user-friendly style is complemented by diverse diagrams, graphics and business flow charts with decision trees to support effective management and decision making. Provides tested strategies and lessons in an engaging and user-friendly style supplemented by tailored pedagogy, training tips and overview sidebars Case studies are interspersed throughout each chapter to support key concepts and best practices. Enhanced by use of numerous detailed graphics, tables and flow charts
Book Synopsis Human Nature in an Age of Biotechnology by : Tamar Sharon
Download or read book Human Nature in an Age of Biotechnology written by Tamar Sharon and published by Springer Science & Business Media. This book was released on 2013-10-11 with total page 249 pages. Available in PDF, EPUB and Kindle. Book excerpt: New biotechnologies have propelled the question of what it means to be human – or posthuman – to the forefront of societal and scientific consideration. This volume provides an accessible, critical overview of the main approaches in the debate on posthumanism, and argues that they do not adequately address the question of what it means to be human in an age of biotechnology. Not because they belong to rival political camps, but because they are grounded in a humanist ontology that presupposes a radical separation between human subjects and technological objects. The volume offers a comprehensive mapping of posthumanist discourse divided into four broad approaches—two humanist-based approaches: dystopic and liberal posthumanism, and two non-humanist approaches: radical and methodological posthumanism. The author compares and contrasts these models via an exploration of key issues, from human enhancement, to eugenics, to new configurations of biopower, questioning what role technology plays in defining the boundaries of the human, the subject and nature for each. Building on the contributions and limitations of radical and methodological posthumanism, the author develops a novel perspective, mediated posthumanism, that brings together insights in the philosophy of technology, the sociology of biomedicine, and Michel Foucault’s work on ethical subject constitution. In this framework, technology is neither a neutral tool nor a force that alienates humanity from itself, but something that is always already part of the experience of being human, and subjectivity is viewed as an emergent property that is constantly being shaped and transformed by its engagements with biotechnologies. Mediated posthumanism becomes a tool for identifying novel ethical modes of human experience that are richer and more multifaceted than current posthumanist perspectives allow for. The book will be essential reading for students and scholars working on ethics and technology, philosophy of technology, poststructuralism, technology and the body, and medical ethics.
Book Synopsis Building Backwards to Biotech by : Stephanie Wisner
Download or read book Building Backwards to Biotech written by Stephanie Wisner and published by . This book was released on 2022-05-31 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: Ever wonder how medicines and vaccines enter the marketplace? Why they are so expensive? Most people have heard about Theranos, a story of failure: how do biotechnology start-ups actually succeed? In Building Backwards to Biotech, author Stephanie A. Wisner demystifies the subjects of biotechnology, start-ups, and finance to answer these questions. Wisner unlocks the secrets of how to build a biotech company successfully by keeping one process always in mind: Building Backwards. In this book you will understand the concept of Building Backwards and how it can: Increase your chances of starting a "winning" company Inform capital raising Lead to a strong clinical and scientific strategy Mitigate business and scientific risk from the outset Wisner believes in the power of entrepreneurship to drive cutting-edge science to market successfully and its ability to help people suffering with diseases currently considered untreatable. She believes good science combined with innovative business practices has the power to literally save and enrich lives. Building Backwards to Biotech will make it easier for interested individuals to bring this kind of work to a waiting world.
Book Synopsis THE ADOPTION AND ADAPTION OF OPEN INNOVATION: EMPIRICAL EVIDENCE FROM THE BIOTECHNOLOGY INDUSTRY by : RAFAELA KUNZ
Download or read book THE ADOPTION AND ADAPTION OF OPEN INNOVATION: EMPIRICAL EVIDENCE FROM THE BIOTECHNOLOGY INDUSTRY written by RAFAELA KUNZ and published by Archers & Elevators Publishing House. This book was released on with total page 266 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Book Synopsis Building Capabilities for Productive Development by : Jorge Cornick
Download or read book Building Capabilities for Productive Development written by Jorge Cornick and published by Inter-American Development Bank. This book was released on 2018-06-29 with total page 320 pages. Available in PDF, EPUB and Kindle. Book excerpt: Productive development policies (PDPs) are notoriously hard. They involve a daunting level of technical detail, require public-private collaboration, are in constant danger of capture, and demand time consistency hard to achieve in a politically volatile region. Nevertheless, the potential of PDPs to revitalize the regionâs economic performance and spur productivity growth cannot be ignored. This book takes an in-depth look at 17 cases involving productive development agencies from Argentina, Brazil, Costa Rica and Uruguay, identifying key features of institutional design and agency-level practices that make success more likely in this difficult policy arena. Careful study of these experiences might help successful productive development policies gain currency across the region. The cases in this book should not be seen as the exceptions that prove the rule of lackluster PDP performance, but rather as examples that demonstrate the rule can be broken.
Book Synopsis Science Lessons by : Gordon M. Binder
Download or read book Science Lessons written by Gordon M. Binder and published by Harvard Business Review Press. This book was released on 2008 with total page 326 pages. Available in PDF, EPUB and Kindle. Book excerpt: Under Gordon Binder's leadership, Amgen became the world's largest and most successful biotech company in the world. This text describes what it really takes to manage risk, financing, creative employees, and intellectual property on the international stage.
Book Synopsis Effective Technology Transfer in Biotechnology by : Oliver Uecke
Download or read book Effective Technology Transfer in Biotechnology written by Oliver Uecke and published by World Scientific. This book was released on 2015-01-06 with total page 292 pages. Available in PDF, EPUB and Kindle. Book excerpt: Biotechnology is referred to as one of the key enabling technologies of the 21st century. It has the potential to offer solutions for a number of health and resource-based problems the world is facing, such as unmet medical needs and fossil fuel dependency. Considerable effort and investment has been expended in recent years to try and improve the outcomes of technology transfer in order to fulfill this potential. This book presents seventeen best-practice case studies on the topic of effective technology transfer in biotechnology. The selected case studies focus on technology transfer offices, funding models, incubators, education and clusters. Each presents an overview of an initiative that was deployed in Europe with the aim of supporting and stimulating the transfer of biotechnology discoveries and technologies from research laboratories to society. Readers are provided with a critical assessment of each initiative and policy makers, entrepreneurs, cluster managers and research institute managers will find inspiring lessons they can draw on when developing and implementing similar initiatives elsewhere. These cases are the product of research undertaken as part of the ETTBio (Effective Technology Transfer in Biotechnology) project, co-financed by the European Union (ERDF — European Regional Development Fund) and made possible by the INTERREG IVC Programme. ETTBio commenced in January 2012 and concluded in December 2014. Contents:Technology Transfer Office (TTO):Case Study 1: A Look Inside Imperial College's TTOCase Study 2: Technology Transfer at VIBCase Study 3: The Creation of a New Technology Transfer OfficeCase Study 4: A Model for IP Transfer and Shareholding for University Spin-Offs: The "Dresden Model"Funding:Case Study 5: Environmental Success Factors of Imperial College's TTOCase Study 6: The Industrial Research FundCase Study 7: Regional Innovation Vouchers as an Effective Tool for Supporting Technology TransferCase Study 8: Public Funds for Patenting, Valorization and Science-Industry CollaborationIncubators:Case Study 9: The Imperial BioincubatorCase Study 10: Idea Lab — A Platform for Students to Develop New IdeasEducation:Case Study 11: Entrepreneurship and Technology Transfer Education at the Vrije Universiteit BrusselCase Study 12: BioEmprenedor XXI: Guidance Program for Starting Up and Growing Companies in the Life Sciences ArenaCase Study 13: Education for ScientistsClusters:Case Study 14: The Biocat Model: Managing the Bioregion of CataloniaCase Study 15: The Effects of a Cluster on a Spin-Off — The Foundation of AblynxCase Study 16: Brokerage Event: Matching International R&D projectsCase Study 17: The DRESDEN-concept: A Focus on Shared Services and Facilities Readership: Policy makers, entrepreneurs, cluster managers and research institute managers in biotechnology. Key Features:Focuses on effective technology transfer in the European contextTechnology specific focus on biotechnologyIdentifies and provides a detailed examination of best practice case studies in technology transfer across Europe. These include both highly experienced regions such as London and Flanders as well as "newcomers" such as Poland and EstoniaKeywords:Technology Transfer;Biotechnology;Effectiveness;Efficiency;Commercialization;Research;Funding;Cluster;Education;Technology Transfer Offices;Incubation
Author :National Academies of Sciences, Engineering, and Medicine Publisher :National Academies Press ISBN 13 :0309452058 Total Pages :231 pages Book Rating :4.3/5 (94 download)
Book Synopsis Preparing for Future Products of Biotechnology by : National Academies of Sciences, Engineering, and Medicine
Download or read book Preparing for Future Products of Biotechnology written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2017-07-28 with total page 231 pages. Available in PDF, EPUB and Kindle. Book excerpt: Between 1973 and 2016, the ways to manipulate DNA to endow new characteristics in an organism (that is, biotechnology) have advanced, enabling the development of products that were not previously possible. What will the likely future products of biotechnology be over the next 5â€"10 years? What scientific capabilities, tools, and/or expertise may be needed by the regulatory agencies to ensure they make efficient and sound evaluations of the likely future products of biotechnology? Preparing for Future Products of Biotechnology analyzes the future landscape of biotechnology products and seeks to inform forthcoming policy making. This report identifies potential new risks and frameworks for risk assessment and areas in which the risks or lack of risks relating to the products of biotechnology are well understood.
Book Synopsis Biocatalysis by : Gonzalo de Gonzalo
Download or read book Biocatalysis written by Gonzalo de Gonzalo and published by Royal Society of Chemistry. This book was released on 2017-11-02 with total page 532 pages. Available in PDF, EPUB and Kindle. Book excerpt: Implementing biocatalytic strategies in an industrial setting is a challenging task, especially when commercial scale necessitates a balance between industrial need and economic viability. With invited contributions from a wide range of chemical and pharmaceutical companies, this book bridges the gap between academia and industry. Contributors discuss current processes, types of biocatalysts and improvements, industrial motivation and the key aspects needed for economic success. Focussing on industry related issues, this book will be a useful tool for future research by both practitioners and academics.
Book Synopsis Managing Biotechnology by : Francoise Simon
Download or read book Managing Biotechnology written by Francoise Simon and published by John Wiley & Sons. This book was released on 2017-09-01 with total page 320 pages. Available in PDF, EPUB and Kindle. Book excerpt: A comprehensive overview of the new business context for biopharma companies, featuring numerous case studies and state-of-the-art marketing models Biotechnology has developed into a key innovation driver especially in the field of human healthcare. But as the biopharma industry continues to grow and expand its reach, development costs are colliding with aging demographics and cost-containment policies of private and public payers. Concurrently, the development and increased affordability of sophisticated digital technologies has fundamentally altered many industries including healthcare. The arrival of new information technology (infotech) companies on the healthcare scene presents both opportunities and challenges for the biopharma business model. To capitalize on new digital technologies from R&D through commercialization requires industry leaders to adopt new business models, develop new digital and data capabilities, and partner with innovators and payers worldwide. Written by two experts, both of whom have had decades of experience in the field, this book provides a comprehensive overview of the new business context and marketing models for biotech companies. Informed by extensive input by senior biotech executives and leading consultancies serving the industry, it analyzes the strategies and key success factors for the financing, development, and commercialization of novel therapeutic products, including strategies for engagement with patients, physicians and healthcare payers. Throughout case studies provide researchers, corporate marketers, senior managers, consultants, financial analysts, and other professionals involved in the biotech sector with insights, ideas, and models. JACQUALYN FOUSE, PhD, RETIRED PRESIDENT AND CHIEF OPERATING OFFICER, CELGENE “Biotech companies have long been innovators, using the latest technologies to enable cutting edge science to help patients with serious diseases. This book is essential to help biotech firms understand how they can–and must–apply the newest technologies including disruptive ones, alongside science, to innovate and bring new value to the healthcare system.” BRUCE DARROW, MD, PhD, CHIEF MEDICAL INFORMATION OFFICER, MOUNT SINAI HEALTH SYSTEM “Simon and Giovannetti have written an essential user’s manual explaining the complicated interplay of the patients who deserve cutting-edge medical care, the biotechnology companies (big and small) creating the breakthroughs, and the healthcare organizations and clinicians who bridge those worlds.” EMMANUEL BLIN, FORMER CHIEF STRATEGY OFFICER AND SENIOR VICE PRESIDENT, BRISTOL-MYERS SQUIBB “If you want to know where biopharma is going, read this book! Our industry is facing unprecedented opportunities driven by major scientific breakthroughs, while transforming itself to address accelerated landscape changes driven by digital revolutions and the emergence of value-based healthcare worldwide. In this ever-changing context, we all need to focus everything we do on the patients. They are why we exist as an industry, and this is ultimately what this insightful essay is really about.” JOHN MARAGANORE, PRESIDENT AND CHIEF EXECUTIVE OFFICER, ALNYLAM PHARMACEUTICALS “Since the mapping of the human genome was completed nearly 15 years ago, the biotechnology industry has led the rapid translation of raw science to today’s innovative medicines. However, the work does not stop in the lab. Delivering these novel medicines to patients is a complex and multifaceted process, which is elegantly described in this new book.”
